Jefferies Group LLC Incyte Corp Call Options Transaction History

Jefferies Group LLC

$10.2 Billion
Q3 2022

Call Options

21 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Sep 21, 2023	SELL	$66.18 - $83.18 $330,900 - $415,900	-5,000 Reduced 31.45%	10,900 $828,000
Q2 2022 Aug 15, 2022	SELL	$66.18 - $83.18 $330,900 - $415,900	-5,000 Reduced 31.45%	10,900 $828,000
Q1 2022 Sep 21, 2023	BUY	$66.02 - $79.71 $851,658 - $1.03 Million	12,900 Added 430.0%	15,900 $1.26 Million
Q1 2022 May 16, 2022	BUY	$66.02 - $79.71 $851,658 - $1.03 Million	12,900 Added 430.0%	15,900 $1.26 Million
Q2 2021 Sep 21, 2023	SELL	$79.87 - $87.53 $3.35 Million - $3.68 Million	-42,000 Reduced 93.33%	3,000 $252,000
Q2 2021 Aug 20, 2021	SELL	$79.87 - $87.53 $23.7 Million - $26 Million	-297,000 Reduced 99.0%	3,000 $252,000
Q2 2021 Aug 16, 2021	BUY	$79.87 - $87.53 $20.4 Million - $22.3 Million	255,000 Added 566.67%	300,000 $252,000
Q1 2021 Sep 21, 2023	BUY	$76.02 - $100.5 $2.49 Million - $3.29 Million	32,700 Added 265.85%	45,000 $3.66 Million
Q1 2021 May 14, 2021	BUY	$76.02 - $100.5 $2.49 Million - $3.29 Million	32,700 Added 265.85%	45,000 $3.66 Million
Q4 2020 Sep 21, 2023	BUY	$80.74 - $97.7 $113,036 - $136,780	1,400 Added 12.84%	12,300 $1.07 Million
Q4 2020 Feb 16, 2021	BUY	$80.74 - $97.7 $161,480 - $195,400	2,000 Added 19.42%	12,300 $1.07 Million
Q2 2020 Aug 14, 2020	SELL	$74.18 - $108.93 $89,016 - $130,716	-1,200 Reduced 10.43%	10,300 $1.07 Million
Q1 2020 May 15, 2020	SELL	$63.18 - $85.97 $562,302 - $765,133	-8,900 Reduced 43.63%	11,500 $842,000
Q4 2019 Feb 13, 2020	BUY	$73.04 - $95.72 $314,072 - $411,596	4,300 Added 26.71%	20,400 $1.78 Million
Q3 2019 Nov 13, 2019	BUY	$72.82 - $86.52 $1.08 Million - $1.28 Million	14,800 Added 1138.46%	16,100 $1.2 Million
Q2 2019 Aug 14, 2019	SELL	$73.52 - $88.7 $2.95 Million - $3.56 Million	-40,100 Reduced 96.86%	1,300 $110,000
Q1 2019 May 15, 2019	SELL	$63.56 - $88.17 $2.3 Million - $3.19 Million	-36,200 Reduced 46.65%	41,400 $3.56 Million
Q4 2018 Feb 14, 2019	BUY	$58.5 - $69.94 $1.61 Million - $1.93 Million	27,600 Added 55.2%	77,600 $4.94 Million
Q3 2018 Nov 14, 2018	SELL	$61.75 - $74.23 $617,500 - $742,300	-10,000 Reduced 16.67%	50,000 $3.45 Million
Q2 2018 Aug 14, 2018	BUY	$60.85 - $83.98 $2.6 Million - $3.59 Million	42,800 Added 248.84%	60,000 $4.02 Million
Q1 2018 May 15, 2018	BUY	$83.06 - $100.98 $1.43 Million - $1.74 Million	17,200 New	17,200 $1.43 Million

Others Institutions Holding INCY

# of Institutions

643

Shares Held

186M

Call Options Held

714K

Put Options Held

557K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $15.3B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.

Account